Advertisement

Search Results

Advertisement



No results found for ","

Suggestions:

  • Ensure words are spelled correctly.
  • Try rephrasing keywords or using synonyms.
  • Try less specific keywords.
Advertisement

Advertisement



Jun
04
Today In Oncology
Vorasidenib Delays Disease Progression or Death in Patients With Grade 2 IDH-Mutated Glioma
Radiation May Be Safely Omitted in Select Patients With Locally Advanced Rectal Cancer
Adjuvant Osimertinib Improves Survival in Patients With Resected EGFR-Mutated NSCLC
Nivolumab May Reduce Risk of Disease Progression or Death in Previously Untreated Patients With Hodgkin Lymphoma Compared to Brentuximab Vedotin
Mirvetuximab Soravtansine Improves Survival in Patients With Recurrent Ovarian Cancer
View More 
Advertisement
© 2023 HSP News Service, L.L.C.
Designed by Harborside